Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adverum Biotechnologies, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 225K | Mar 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADVM | Adverum Biotechnologies, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Sep 19, 2022 | 1 | -$4.57K | 4 | Sep 21, 2022 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Sep 14, 2022 | 1 | $0 | 4/A | Sep 21, 2022 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | May 17, 2022 | 1 | $8.23K | 4 | May 19, 2022 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Feb 7, 2022 | 1 | $0 | 4 | Feb 9, 2022 | Chief Medical Officer |
ADVM | Adverum Biotechnologies, Inc. | Feb 7, 2022 | 0 | $0 | 3 | Feb 9, 2022 | Chief Medical Officer |